<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-16707</identifier>
<setSpec>0210-9433</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:creator>Coca, A</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Ediciones Doyma, S.L.</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Med. integral (Ed. impr.);40(8): 335-337, nov. 2002.</dc:source>
<dc:identifier>ibc-16707</dc:identifier>
<dc:title xml:lang="es">Relevancia cl√≠nica del supuesto aumento de la morbilidad cardiovascular asociada al uso de inhibidores de la ciclooxigenasa tipo 2</dc:title>
<dc:subject>^d29633</dc:subject>
<dc:subject>^d30165^s22020</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2359^s22036</dc:subject>
<dc:type>article</dc:type>
<dc:date>200211</dc:date>
</metadata>
</record>
</ibecs-document>
